DE69430545T2 - Verwendung von penciclovir zur behandlung von postherpetischer neuralgie - Google Patents

Verwendung von penciclovir zur behandlung von postherpetischer neuralgie

Info

Publication number
DE69430545T2
DE69430545T2 DE69430545T DE69430545T DE69430545T2 DE 69430545 T2 DE69430545 T2 DE 69430545T2 DE 69430545 T DE69430545 T DE 69430545T DE 69430545 T DE69430545 T DE 69430545T DE 69430545 T2 DE69430545 T2 DE 69430545T2
Authority
DE
Germany
Prior art keywords
penciclovir
postherpetic neuralgia
treating postherpetic
treating
neuralgia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69430545T
Other languages
English (en)
Other versions
DE69430545D1 (de
Inventor
James Boon
Ronald Griffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69430545(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939320485A external-priority patent/GB9320485D0/en
Priority claimed from GB939321255A external-priority patent/GB9321255D0/en
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Application granted granted Critical
Publication of DE69430545D1 publication Critical patent/DE69430545D1/de
Publication of DE69430545T2 publication Critical patent/DE69430545T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69430545T 1993-10-05 1994-10-04 Verwendung von penciclovir zur behandlung von postherpetischer neuralgie Expired - Lifetime DE69430545T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939320485A GB9320485D0 (en) 1993-10-05 1993-10-05 Pharmaceuticals
GB939321255A GB9321255D0 (en) 1993-10-14 1993-10-14 Pharmaceuticals
PCT/GB1994/002156 WO1995009632A1 (en) 1993-10-05 1994-10-04 Use of penciclorin for the treatment of post-therapeutic neuralgia

Publications (2)

Publication Number Publication Date
DE69430545D1 DE69430545D1 (de) 2002-06-06
DE69430545T2 true DE69430545T2 (de) 2002-11-07

Family

ID=26303637

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69430545T Expired - Lifetime DE69430545T2 (de) 1993-10-05 1994-10-04 Verwendung von penciclovir zur behandlung von postherpetischer neuralgie

Country Status (17)

Country Link
US (1) US5866581A (de)
EP (1) EP0804199B1 (de)
JP (1) JP3768527B2 (de)
CN (1) CN1082816C (de)
AP (1) AP616A (de)
AT (1) ATE216885T1 (de)
AU (1) AU7788494A (de)
CA (1) CA2173505C (de)
CY (1) CY2375B1 (de)
DE (1) DE69430545T2 (de)
DK (1) DK0804199T3 (de)
ES (1) ES2176258T3 (de)
HK (1) HK1004115A1 (de)
HU (1) HU226472B1 (de)
IL (1) IL111138A (de)
PT (1) PT804199E (de)
WO (1) WO1995009632A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9600847D0 (en) 1996-01-16 1996-03-20 Smithkline Beecham Plc Pharmaceuticals
PT1093366E (pt) * 1998-07-09 2005-02-28 Warner Lambert Co Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster
US6419934B1 (en) 1999-02-24 2002-07-16 Edward L. Tobinick TNF modulators for treating neurological disorders associated with viral infection
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
JP2015520144A (ja) * 2012-05-11 2015-07-16 アクロン・モレキュールズ・アクチェンゲゼルシャフトAkron Molecules Ag 疼痛の治療のための化合物の使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.

Also Published As

Publication number Publication date
HU226472B1 (en) 2008-12-29
ATE216885T1 (de) 2002-05-15
ES2176258T3 (es) 2002-12-01
CA2173505A1 (en) 1995-04-13
CA2173505C (en) 2005-03-29
JP3768527B2 (ja) 2006-04-19
HK1004115A1 (en) 1998-11-20
PT804199E (pt) 2002-09-30
US5866581A (en) 1999-02-02
CY2375B1 (en) 2004-06-04
AP9400684A0 (en) 1994-10-31
HU9600882D0 (en) 1996-05-28
IL111138A0 (en) 1994-12-29
WO1995009632A1 (en) 1995-04-13
CN1135180A (zh) 1996-11-06
EP0804199A1 (de) 1997-11-05
JPH10513434A (ja) 1998-12-22
AP616A (en) 1997-09-15
CN1082816C (zh) 2002-04-17
EP0804199B1 (de) 2002-05-02
IL111138A (en) 1997-04-15
HUT74076A (en) 1996-10-28
AU7788494A (en) 1995-05-01
DE69430545D1 (de) 2002-06-06
DK0804199T3 (da) 2002-08-19

Similar Documents

Publication Publication Date Title
DE69434672D1 (de) Verfahren zur behandlung von hühnereiern
DE69224080T2 (de) Verwendung von nsaid zur behandlung von demenz
DE69421912D1 (de) Methode zur behandlung von wasser
DE4391418T1 (de) Vorrichtung zur elektrochemischen Behandlung von Wasser
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
DE69703649D1 (de) Behandlung von deagglomerierten teilchen mit plasmaaktivierter spezies
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
DE69316203T2 (de) Elektrochemische behandlung von oberflächen
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
ATE176399T1 (de) Verfahren zur inaktivierung von spermien
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69527140T2 (de) Wirkstoff zur prävention oder behandlung von osteoporose
DE69425131T2 (de) Verwendung von clavulansäure und einem antibiotikum zur behandlung von infektionen
ATA902789A (de) Verfahren zur katalytischen behandlung von abwasser
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
DE69621447D1 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
DE69328615D1 (de) Verfahren zur behandlung von viehhaltungsgülle
DE69331833T2 (de) Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose
DE69939723D1 (de) Verwendung von Intereferon Gamma zur Behandlung von Herzhypertrophie
DE69430545T2 (de) Verwendung von penciclovir zur behandlung von postherpetischer neuralgie
DE59808788D1 (de) Verfahren zur Behandlung von natürlichen oder synthetischen Polyamidfasermaterialien
DE69404725T2 (de) Verfahren zur elektrolytischen Behandlung von Altbatterien
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE59305800D1 (de) Werkzeug zur behandlung von oberflächen von bauteilen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN